mhurhangee/ep-ind-claims huggingface dataset:
A 3D bending device for bending a wire, which is formed with a first leg, a second leg and an angled portion between the legs (12, 14), into a 3-dimensional shape for the production of machine elements of electric machines, comprising: a first holding member for holding the wire by the first leg and a second holding member for holding the wire by the second leg, a first relative movement device for relatively moving the first holding member and the second holding member in a first relative movement with a first movement axis in order to produce a torsion angle (α 1) of the first leg relative to an imaginary connecting line between the central axes of the legs (12, 14), a second relative movement device for relatively moving the first holding member and the second holding member in a second relative movement with a second movement axis in order to produce a torsion angle (α 2) of the second leg relative to the imaginary connecting line between the central axes of the legs (12, 14), characterized by a third relative movement device for moving the first holding member relative to the second holding member in a third relative movement with a third movement axis in order to change the distance (so, s) between the central axes of the legs (12, 14), wherein the third relative movement device is a linear movement device for relatively moving the first holding member and the second holding member in the direction of a first linear movement axis (x) as a third movement axis. a first holding member for holding the wire by the first leg and a second holding member for holding the wire by the second leg, a first relative movement device for relatively moving the first holding member and the second holding member in a first relative movement with a first movement axis in order to produce a torsion angle (α 1) of the first leg relative to an imaginary connecting line between the central axes of the legs (12, 14), a second relative movement device for relatively moving the first holding member and the second holding member in a second relative movement with a second movement axis in order to produce a torsion angle (α 2) of the second leg relative to the imaginary connecting line between the central axes of the legs (12, 14), characterized by a third relative movement device for moving the first holding member relative to the second holding member in a third relative movement with a third movement axis in order to change the distance (so, s) between the central axes of the legs (12, 14), wherein the third relative movement device is a linear movement device for relatively moving the first holding member and the second holding member in the direction of a first linear movement axis (x) as a third movement axis.
A method of manufacturing a data page for a book-like document, in particular a document of value or security document, which comprises a data carrier and a tab made of a flexible tape material which, in a connection zone, is connected to an edge region of the data carrier forming an overlap region and which comprises a protruding zone, - wherein the flexible tape material is fed to a gripping device by a feeding device, said gripping device comprising at least one first gripper member and at least one second gripper member, with at least one of the gripper members (44, 46) being controllable in such a manner as to be moved independently of the other one, - wherein the second gripper member grasps an end of the flexible tape material held by the first gripper member and is moved to a working position provided separately from the first gripper member in the longitudinal direction of the tape and is positioned at a distance from the first gripper member which corresponds at least to the length of the tab, - wherein a third gripper member of the gripping device is positioned between the first and second gripper members (44, 46) and is closed for grasping the flexible tape material held between the first and second gripper members (44, 46) in such a manner that the connection zone of the tab protrudes from the third gripper member, and - wherein the protruding connection zone of the flexible tape material is moved towards, and positioned at, the edge region of the data carrier by the third gripper member and is nondetachably connected to said data carrier. - wherein the flexible tape material is fed to a gripping device by a feeding device, said gripping device comprising at least one first gripper member and at least one second gripper member, with at least one of the gripper members (44, 46) being controllable in such a manner as to be moved independently of the other one, - wherein the second gripper member grasps an end of the flexible tape material held by the first gripper member and is moved to a working position provided separately from the first gripper member in the longitudinal direction of the tape and is positioned at a distance from the first gripper member which corresponds at least to the length of the tab, - wherein a third gripper member of the gripping device is positioned between the first and second gripper members (44, 46) and is closed for grasping the flexible tape material held between the first and second gripper members (44, 46) in such a manner that the connection zone of the tab protrudes from the third gripper member, and - wherein the protruding connection zone of the flexible tape material is moved towards, and positioned at, the edge region of the data carrier by the third gripper member and is nondetachably connected to said data carrier.
An ophthalmic fluid applicator comprising: an inlet end for connection to a fluid supply device; an outlet end for attachment to a needle element, and a main tubular container body connecting the inlet end and the outlet end; wherein the main tubular container body comprises at least in part a flexible wall portion providing a variable inner volume to the tubular container body and a longitudinally arranged rigid wall portion connecting the inlet end and the outlet end, and wherein the flexible wall portion is longitudinally arranged between the inlet end and the outlet end; characterised in that the inlet end comprises an inlet one-way valve. an inlet end for connection to a fluid supply device; an outlet end for attachment to a needle element, and a main tubular container body connecting the inlet end and the outlet end; wherein the main tubular container body comprises at least in part a flexible wall portion providing a variable inner volume to the tubular container body and a longitudinally arranged rigid wall portion connecting the inlet end and the outlet end, and wherein the flexible wall portion is longitudinally arranged between the inlet end and the outlet end; characterised in that the inlet end comprises an inlet one-way valve.
Method for the forming of a nameplate or registration plate of essentially-rectangular shape, including the following steps: - bonding of a so-called intermediary sheet (3, 10) of dimensions essentially the same as the nameplate or registration plate to be formed, against the pre-glued interior face of a rigid transparent plate, of which the dimensions also correspond to the dimensions of the nameplate or registration plate to be formed; - bonding of another so-called additional sheet (4, 11) against the interior face of this intermediary sheet (3, 10), being of dimensions essentially equal to those of the nameplate or registration plate to be formed, with the said additional sheet (4, 11) being able to bear markings that are visible on the plate thus obtained, via transparency through the said intermediary plate; characterized by the fact that the intermediary sheet is a three-layer complex composed of an upper face, a transparent intermediary support sheet and an adhesive film, with the latter being temporarily protected by a protective film, with the said upper face being endowed with a pre-cut extending over part of its surface, and being notably able to extend over its entire peripheral edging, with the process also including the removal of the central part of the upper face, such as defined by the pre-cut, so as to leave only the intermediary support sheet at the area thus de-garnished, other than on the remainder of its surface or peripheral edging, prior to its securing against the pre-glued interior face of the transparent rigid plate. - bonding of a so-called intermediary sheet (3, 10) of dimensions essentially the same as the nameplate or registration plate to be formed, against the pre-glued interior face of a rigid transparent plate, of which the dimensions also correspond to the dimensions of the nameplate or registration plate to be formed; - bonding of another so-called additional sheet (4, 11) against the interior face of this intermediary sheet (3, 10), being of dimensions essentially equal to those of the nameplate or registration plate to be formed, with the said additional sheet (4, 11) being able to bear markings that are visible on the plate thus obtained, via transparency through the said intermediary plate;
A method for displaying a first portion (552, 652) of a markup language document (550, 650) on a first device and displaying a second portion (554, 654) of the markup language document (550, 650) on a second device for interaction with the first portion (552, 652), comprising: parsing the markup language document (550, 650) using the first device; rendering the first portion (552, 652) of the markup language document (550, 650) based at least in part upon the parsing, using the first device, for displaying on a display coupled with the first device; sending the second portion (554, 654) of the markup language document (550, 650) to the second device, using a remote device tag (402, 558, 658) in the markup language document (550, 650) based at least in part on the parsing, the second portion (554, 654) sent for displaying by the second device; characterized in that the interaction with the first portion comprises receiving an indication of an input interaction with the second portion (554, 654) of the markup language document (550, 650) from the second device; and the method further comprises one or more of: updating the rendered first portion on the first device, based on the input interaction with the second portion (554, 654); and sending an updated second portion (554, 654) to the second device, based on the input interaction with the second portion (554, 654). parsing the markup language document (550, 650) using the first device; rendering the first portion (552, 652) of the markup language document (550, 650) based at least in part upon the parsing, using the first device, for displaying on a display coupled with the first device; sending the second portion (554, 654) of the markup language document (550, 650) to the second device, using a remote device tag (402, 558, 658) in the markup language document (550, 650) based at least in part on the parsing, the second portion (554, 654) sent for displaying by the second device; characterized in that the interaction with the first portion comprises receiving an indication of an input interaction with the second portion (554, 654) of the markup language document (550, 650) from the second device; and the method further comprises one or more of: updating the rendered first portion on the first device, based on the input interaction with the second portion (554, 654); and sending an updated second portion (554, 654) to the second device, based on the input interaction with the second portion (554, 654). updating the rendered first portion on the first device, based on the input interaction with the second portion (554, 654); and sending an updated second portion (554, 654) to the second device, based on the input interaction with the second portion (554, 654).
An assembly for introducing a medicament into a body cavity, the assembly comprising: an elongate tube having a proximal end, a distal end, an outer surface, an inner surface and an opening extending from the distal end to the proximal end, the proximal end adapted to support a medicament, the elongate tube comprising at least one radial discontinuity adjacent the distal end and extending inwardly from the inner surface of the tube; and a plunger rod having an elongate body with a distal end and a proximal end, the plunger rod adapted to be slidably engaged within the tube, the plunger rod comprising at least two axially spaced projections adjacent the distal end of the elongate body that cooperatively engages with the at least one radial discontinuity, the plunger rod including an opening adjacent each of the at least two axially spaced projections to allow flexion of the plunger rod adjacent each of the at least two axially spaced projections; wherein the at least one radial discontinuity on the elongate tube cooperatively engages between the at least two axially spaced projections on the elongate body of the plunger rod, such that spontaneous movement of the plunger rod distally or proximally with respect to the elongate tube is substantially prevented, wherein the proximal end of the elongate tube comprises at least two tongues adapted to support a medicament. an elongate tube having a proximal end, a distal end, an outer surface, an inner surface and an opening extending from the distal end to the proximal end, the proximal end adapted to support a medicament, the elongate tube comprising at least one radial discontinuity adjacent the distal end and extending inwardly from the inner surface of the tube; and a plunger rod having an elongate body with a distal end and a proximal end, the plunger rod adapted to be slidably engaged within the tube, the plunger rod comprising at least two axially spaced projections adjacent the distal end of the elongate body that cooperatively engages with the at least one radial discontinuity, the plunger rod including an opening adjacent each of the at least two axially spaced projections to allow flexion of the plunger rod adjacent each of the at least two axially spaced projections; wherein the at least one radial discontinuity on the elongate tube cooperatively engages between the at least two axially spaced projections on the elongate body of the plunger rod, such that spontaneous movement of the plunger rod distally or proximally with respect to the elongate tube is substantially prevented, wherein the proximal end of the elongate tube comprises at least two tongues adapted to support a medicament.
A medical inhaler or a nebulizer for medical fluids comprising a nozzle fixing assembly, the assembly being adapted to be substantially pressure tight when a nozzle body is inserted, comprising: - an elastically deformable seal element, having a continuous opening capable of receiving a nozzle body, said seal element and said nozzle body each having a high pressure side (2A, 4A) and an outlet side (2B, 4B); - a pressure element with a high pressure side, said side being arranged to face the high pressure side of the seal element; wherein (i) the high pressure side of the seal element is substantially flat and lies in a plane being perpendicular to a longitudinal axis of the seal element, wherein said longitudinal axis follows said continuous opening, and (ii) the high pressure side of the pressure element is inclined or sloped in a way that, in the assembled state, the distance between the surface of the high pressure side of the pressure element and the high pressure side of the seal element decreases from the center to the corners or circumference of the surface, wherein said central region is a region facing said continuous opening when following said longitudinal axis. - an elastically deformable seal element, having a continuous opening capable of receiving a nozzle body, said seal element and said nozzle body each having a high pressure side (2A, 4A) and an outlet side (2B, 4B); - a pressure element with a high pressure side, said side being arranged to face the high pressure side of the seal element; wherein (i) the high pressure side of the seal element is substantially flat and lies in a plane being perpendicular to a longitudinal axis of the seal element, wherein said longitudinal axis follows said continuous opening, and (ii) the high pressure side of the pressure element is inclined or sloped in a way that, in the assembled state, the distance between the surface of the high pressure side of the pressure element and the high pressure side of the seal element decreases from the center to the corners or circumference of the surface, wherein said central region is a region facing said continuous opening when following said longitudinal axis. (i) the high pressure side of the seal element is substantially flat and lies in a plane being perpendicular to a longitudinal axis of the seal element, wherein said longitudinal axis follows said continuous opening, and (ii) the high pressure side of the pressure element is inclined or sloped in a way that, in the assembled state, the distance between the surface of the high pressure side of the pressure element and the high pressure side of the seal element decreases from the center to the corners or circumference of the surface, wherein said central region is a region facing said continuous opening when following said longitudinal axis.
A composition comprising buprenorphine and a μ opioid receptor antagonist, wherein the composition is characterized by an Agonist Antagonist Activity Index (AAnAI) of between 0.7 and 2.2; wherein; AAnAI = C max BUP EC 50 C max ANTAGONIST IC 50 wherein, EC 50 represents the half maximal effective serum concentration of buprenorphine, expressed as nM; IC 50 represents the half maximal inhibitory concentration of the μ opioid antagonist in humans, expressed as nM; C max represents the peak serum or plasma concentration of buprenorphine and/or a μ opioid receptor agonist metabolite of buprenorphine, expressed as nM; and C max(ANTAGONIST) represents the peak serum concentration of the μ opioid antagonist and/or a μ opioid receptor antagonist metabolite of said μ opioid antagonist, expressed as nM; wherein the IC 50 and EC 50 values are determined using the GTPγS functional assay; and wherein said antagonist is a compound selected from Compound-1 to Compound-12: pharmaceutically acceptable salt or ester thereof. wherein, EC 50 represents the half maximal effective serum concentration of buprenorphine, expressed as nM; IC 50 represents the half maximal inhibitory concentration of the μ opioid antagonist in humans, expressed as nM; C max represents the peak serum or plasma concentration of buprenorphine and/or a μ opioid receptor agonist metabolite of buprenorphine, expressed as nM; and C max(ANTAGONIST) represents the peak serum concentration of the μ opioid antagonist and/or a μ opioid receptor antagonist metabolite of said μ opioid antagonist, expressed as nM;
A sensor guard, for protecting a sensor of a vehicle, where the sensor guard includes a blade (15a-d) operable to sweep, under the control of an actuator, through a line-of-sight of the sensor when the sensor is arranged to be protected by the sensor guard, characterized in that an extension of the blade (15a-d) in a direction parallel to the line-of-sight when the blade sweeps through the line-of sight is at least five times greater than an extension of the blade (15a-d) in a direction of movement of the blade when the blade sweeps through the line-of sight.
An optical encoder grid plate, suitable for irradiation by visible light or near-infrared light, wherein the optical encoder grid plate is suitable for use in an optical encoder which detects a displacement amount or a displacement direction by receiving reflection light reflected by a reflection surface, wherein the optical encoder grid plate includes a base material whose one of surfaces is the reflection surface, and at least one grid, wherein the at least one grid consists of spaced bars arranged at a predetermined grid width on the reflection surface, wherein metal is used as the base material, and the spaced bars of the grid plate are formed on the reflection surface by a black plated layer, of which a thickness is thinner than 3 μm, wherein an average roughness Ra of the reflection surface of the metal is in a range from 0.008 μm to 0.05 μm.
Vitamin A for use in the treatment of tissue damage in a subject following an injury to the subject, wherein the injury comprises a soft tissue injury, wherein the soft tissue injury is a tendon injury or a ligament injury, wherein the vitamin A is to be administered systemically by oral or intravenous administration to the subject, and wherein: a) the subject is a human subject and the vitamin A is for administration to the subject at a dose of >10,000 to 100,000 IU vitamin A per day; or b) the subject is a horse and the vitamin A is for administration to the horse at a dose of 250 to 500 IU/kg body weight per day. a) the subject is a human subject and the vitamin A is for administration to the subject at a dose of >10,000 to 100,000 IU vitamin A per day; or b) the subject is a horse and the vitamin A is for administration to the horse at a dose of 250 to 500 IU/kg body weight per day.
The use of a modified non-human mammal as an animal model for obesity or obesity-related disorders, wherein the modified non-human mammal (i) is heterozygous for the disruption of the gene encoding LSD1 or (ii) has a deletion of the gene encoding LSD1, said deletion being limited to adipose tissue, wherein said obesity-related disorder is selected from the group consisting of insulin resistance, type II diabetes, fatty liver, non-alcoholic fatty liver disease, endocrine abnormalities and triglyceride storage disease.
A method of determining a susceptibility to Bladder Cancer, the method comprising: analyzing nucleic acid sequence data from a human individual for at least one polymorphic marker in the human SLC14A1 gene; wherein different alleles of the at least one polymorphic marker are associated with different susceptibilities to Bladder Cancer in humans, and determining a susceptibility to Bladder Cancer from the nucleic acid sequence data. analyzing nucleic acid sequence data from a human individual for at least one polymorphic marker in the human SLC14A1 gene; wherein different alleles of the at least one polymorphic marker are associated with different susceptibilities to Bladder Cancer in humans, and determining a susceptibility to Bladder Cancer from the nucleic acid sequence data.